Development of selective drug delivery agents that target tumor cells with minimal toxicity to normal tissues is a major challenge in cancer therapy. Non-toxic bacteria can be used to target solid tumors because, within a patient’s body, they can only be active at a tumor site (where oxygen levels are pathologically low). Prior attempts at […]
Read More